With healthcare costs continuing to rise, affordable and accurate imaging and diagnosis achieved through ultrasound will continue to attract patients, according to a new market report from Fact.MR. The report on the global market for ultrasound systems projects steady growth for the market from 2017 to 2022, from a value of $6 billion in 2017 to $7.8 billion toward the end of 2022 — a compound annual growth rate (CAGR) of 5.5 percent.
Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation AcQMap platform, along with CE Mark approval for its AcQMap contact mapping software.
April 26, 2019 — A 72-year-old woman from northern Michigan became Henry Ford Health System’s 1,000th patient treated ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Dee Dee Wang, M.D., director of structural heart imaging, Henry Ford Hospital, Detroit, Mich., explains how patient ...
This video offers an overview of the Watchman left atrial appendage (LAA) occluder system, including information of its ...
The thickness of the coronary artery wall as measured by magnetic resonance imaging (MRI) is an independent marker for heart disease in women, according to a study published in the journal Radiology: Cardiothoracic Imaging.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Stroke patients examined remotely by a teleneurologist were treated as quickly and effectively after hours as during normal business hours, according to new research by The University of Texas Health Science Center at Houston (UTHealth).
April 24, 2019 — New research from the University of Illinois at Chicago shows that when pharmacies close, people stop ...
Recent months have signaled a new and exciting era in the dynamic world of structural heart disease (SHD). The COAPT ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Orchestra BioMed Inc. has secured Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for its Virtue Sirolimus-Eluting Balloon for the treatment of coronary in-stent restenosis (ISR).
Boston Scientific Corp. announced it has received U.S. Food and Drug Administration (FDA) approval for the Lotus Edge Aortic Valve System. Delivered via a minimally invasive procedure, this transcatheter aortic valve replacement (TAVR) technology is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery.
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may help predict who will be readmitted to the hospital within a month, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
April 22, 2019 — Five cardiovascular professional societies released a new consensus document on optimizing care for ...
The Medicare Hospital Insurance (HI) Trust Fund, which funds Medicare Part A, will only be able to pay full benefits for Medicare beneficiaries until 2026, according to the 2019 annual report from the Medicare Board of Trustees. The Supplementary Medical Insurance (SMI) Trust Fund, which funds Medicare Part B and D, is expected to be adequately financed in all years, but the aging population and rising healthcare costs are projected to grow SMI costs from 2.1 percent of gross domestic product (GDP) in 2018 to approximately 3.7 percent of GDP in 2038.
New guidelines that classified more children as having elevated blood pressure are better at predicting which kids are likely to develop heart disease when they reach adulthood, according to new research in the American Heart Association’s journal Hypertension. The guidelines were issued by the American Academy of Pediatrics (AAP) in 2017 and endorsed by the American Heart Association.